Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Trial on the Effect of a Mitophagy Inducer Urolithin A on Alzheimer's Disease

NCT07842146 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT07842146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07842146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Trial on the Effect of a Mitophagy Inducer Urolithin A on Alzheimer's Disease
Lead sponsor
University Hospital, Akershus
Phase
Not applicable
Overall status
Recruiting
Start date
September 26, 2026
Completion date
October 15, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease (ad), early alzheimer's disease, mild cognitive impairment due to alzheimer's disease